Table 5 Treatment analysis of patients with low BILAG-2004 and high SLEDAI-2000 scores with different cut-off scores used to define active disease with SLEDAI-2000
Treatment increasedTreatment reducedTreatment not changed
BILAG-2004 C or D or E and SLEDAI-2000 ⩾6 (n = 5)2 (40%)03 (60%)
BILAG-2004 C or D or E and SLEDAI-2000 ⩾5 (n = 5)2 (40%)03 (60%)
BILAG-2004 C or D or E and SLEDAI-2000 ⩾4 (n = 11)2 (18.2%)2 (18.2%)7 (63.6%)
BILAG-2004 C or D or E and SLEDAI-2000 ⩾3 (n = 11)2 (18.2%)2 (18.2%)7 (63.6%)
BILAG-2004 C or D or E and SLEDAI-2000 ⩾2 (n = 14)2 (14.3%)2 (14.3%)10 (71.4%)
BILAG-2004 C or D or E and SLEDAI-2000 ⩾1 (n = 15)2 (13.3%)2 (13.3%)11 (73.3%)

  • BILAG, British Isles Lupus Assessment Group (BILAG) index; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.

  • Treatment analysis refers to corticosteroids, antimalarials and cytotoxic treatment.